Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Asia-Pacific Journal of Clinical Oncology, 3(3), p. 148-155, 2007

DOI: 10.1111/j.1743-7563.2007.00101.x

Links

Tools

Export citation

Search in Google Scholar

Phase II trial of anti-idiotypic p53 peptides (Pentrys) plus granulocyte-macrophage colony-stimulating factor in patients with hormone-refractory prostate cancer

Journal article published in 2007 by Ian D. Davis, Guy Toner ORCID, Adam Broad, Louise M. Campano, Mark Rosenthal
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO